Accelerating Progress in Pediatric Cancer
NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.
-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI -
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
New NPS Challenge Aims to Rewrite How the Military Builds Missiles
Officials say focusing on design methods, not hardware, could unlock fast, low‑cost manufacturing for future munitions.
11m watch -
The Value of ‘Pause, Breathe, Summarize’ in Cyber Leadership
A simple framework for clarity when everything feels urgent.
25m listen -
NIST Explains What’s Next for Federal AI Standards
NIST’s Martin Stanley outlines how AI control overlays, risk frameworks and future guidance will support agencies scaling AI systems.
6m watch -
CISA CIO on Agentic AI, Building the Cyber Workforce
Bob Costello discusses deploying agentic AI, speeding cyber approvals and strengthening the federal cybersecurity talent pipeline.
9m watch
